|Day Low/High||16.35 / 16.64|
|52 Wk Low/High||13.06 / 17.33|
Streaming sales will increase nine-fold by 2030 to $28 billion with most of the benefits flowing back to the major music labels.
The licensing pact could happen by September.
Significant increase in the magnitude of the purchase order
If you're going to buy on the dip, this is one heck of a dip.
The French billionaire and Vivendi chairman has failed to explain why a pay-TV and music business like Vivendi needs an advertising firm like Havas.
Big names paying shareholders, but their yields are modest compared with others.
-First Potential Human Application for Avivagen's Proprietary Technology -
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABT, HIHO, KE, LBRDA, SSP, TLRD, VIV Downgrades: CORE, LMNX, PKOH, SIM, TATT, TTEC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.